Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,151,pg/ml,27.0,76.3675,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days) and controlled enrasentan content diet (2400 ppm) (for 112 days),107940,controlled sodium chloride content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days),controlled enrasentan content diet (2400 ppm) (for 112 days) 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,178,pg/ml,12.0,33.9411,MMO:0000073,radioimmunoassay,,0.0,,,,,control condition,107937,control condition,, 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,347,pg/ml,72.0,203.6468,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days),107938,controlled sodium content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days), 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,146,pg/ml,26.0,73.5391,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium chloride content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days) and controlled enrasentan content diet (1200 ppm) (for 112 days),107939,controlled sodium chloride content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days),controlled enrasentan content diet (1200 ppm) (for 112 days)